REVEX Trademark

Trademark Overview

On Friday, July 13, 2018, a trademark application was filed for REVEX with the United States Patent and Trademark Office. The USPTO has given the REVEX trademark a serial number of 88037088. The federal status of this trademark filing is REGISTERED as of Tuesday, February 15, 2022. This trademark is owned by Opiant Pharmaceuticals, Inc.. The REVEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; Pharmaceutical preparation, namely, an opioid antagonist
revex

General Information

Serial Number88037088
Word MarkREVEX
Filing DateFriday, July 13, 2018
Status700 - REGISTERED
Status DateTuesday, February 15, 2022
Registration Number6646685
Registration DateTuesday, February 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2018

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for treating opioid overdoses; Pharmaceutical preparation, namely, an opioid antagonist

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 18, 2018
Primary Code005
First Use Anywhere DateWednesday, December 15, 2021
First Use In Commerce DateWednesday, December 15, 2021

Trademark Owner History

Party NameOpiant Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90401
Party NameOpiant Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90401
Party NameOpiant Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90401

Trademark Events

Event DateEvent Description
Tuesday, February 15, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, January 12, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 11, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 28, 2021STATEMENT OF USE PROCESSING COMPLETE
Monday, December 20, 2021USE AMENDMENT FILED
Monday, December 20, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, July 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 23, 2021EXTENSION 5 GRANTED
Thursday, July 15, 2021EXTENSION 5 FILED
Thursday, July 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 15, 2021TEAS EXTENSION RECEIVED
Thursday, May 6, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 6, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 6, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 27, 2021EXTENSION 4 GRANTED
Wednesday, January 27, 2021EXTENSION 4 FILED
Wednesday, January 27, 2021TEAS EXTENSION RECEIVED
Wednesday, July 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 20, 2020EXTENSION 3 GRANTED
Monday, July 20, 2020EXTENSION 3 FILED
Monday, July 20, 2020TEAS EXTENSION RECEIVED
Thursday, July 16, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 16, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2020EXTENSION 2 GRANTED
Wednesday, February 12, 2020EXTENSION 2 FILED
Wednesday, February 12, 2020TEAS EXTENSION RECEIVED
Friday, July 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 24, 2019EXTENSION 1 GRANTED
Wednesday, July 24, 2019EXTENSION 1 FILED
Wednesday, July 24, 2019TEAS EXTENSION RECEIVED
Tuesday, February 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 12, 2018ASSIGNED TO EXAMINER
Wednesday, November 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 1, 2018ASSIGNED TO EXAMINER
Wednesday, July 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 17, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

revex pharmaceutical opioid namely antagonist overdoses preparation treating products preparations